A single capsule formulation of RHB-104 demonstrates higher anti-microbial growth potency for effective treatment of Crohn’s disease associated with Mycobacterium avium subspecies paratuberculosis

BACKGROUND: Most recently we reported that RHB‑104 triple antibiotics combination in culture is bactericidal and should be effective for treatment of Crohn’s disease (CD)-associated with Mycobacterium avium subspecies paratuberculosis (MAP) (Alcedo et al. in Gut Pathog 14:32, 2016). The combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Qasem, Ahmad, Safavikhasraghi, Mitra, Naser, Saleh A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041445/
https://www.ncbi.nlm.nih.gov/pubmed/27708718
http://dx.doi.org/10.1186/s13099-016-0127-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041445/
https://www.ncbi.nlm.nih.gov/pubmed/27708718
http://dx.doi.org/10.1186/s13099-016-0127-z

Ejemplares similares